D-light autofluorescence in the detection of premalignant airway changes

A multicenter trial

Armin Ernst, Michael J. Simoff, Praveen N. Mathur, Rex C. Yung, John F. Beamis

Research output: Contribution to journalArticle

Abstract

Carcinoma in situ and preinvasive lesions are difficult to detect by white light (WL) bronchoscopy. Autofluorescence (AF) bronchoscopy is an emerging technology that may increase the ability for early detection and curative treatment. We report on the effectiveness of an autofluorescence system to detect class III lesions in a large population. A multicenter prospective, nonrandomized, self-controlled study was performed in 5 university-affiliated tertiary care centers. Patients at high risk for pulmonary malignancies were eligible to undergo WL and AF bronchoscopy. Patients underwent biopsy of all suspicious class III lesions, as well as 2 biopsies from normal areas. Three hundred patients were included in the study; of those, 293 patients were included into the efficacy calculations with 832 biopsies. AF was superior to WL in sensitivity (61.2% vs. 10.6%) for detecting class III lesions (visual changes suggesting dysplasia, carcinoma in situ, or microinvasive cancer). The combined sensitivity was 65.9%. Specificity values were 75.3% and 72.7%, respectively, for AF and WL. On a per-patient basis harboring at least 1 premalignant area, the sensitivity for WL was 21.1% as compared with 84.2% for AF. Three deaths occurred within the study period but were unrelated to the device. In conclusion, the AF system is superior to conventional WL bronchoscopy in detecting premalignant lesions in a population at risk.

Original languageEnglish (US)
Pages (from-to)133-138
Number of pages6
JournalJournal of Bronchology
Volume12
Issue number3
DOIs
StatePublished - Jul 2005

Fingerprint

Multicenter Studies
Bronchoscopy
Light
Photophobia
Carcinoma in Situ
Biopsy
Tertiary Care Centers
Neoplasms
Technology
Equipment and Supplies
Lung
Population
Therapeutics

Keywords

  • Autofluorescence
  • Bronchoscopy
  • Lung cancer
  • Screening

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

D-light autofluorescence in the detection of premalignant airway changes : A multicenter trial. / Ernst, Armin; Simoff, Michael J.; Mathur, Praveen N.; Yung, Rex C.; Beamis, John F.

In: Journal of Bronchology, Vol. 12, No. 3, 07.2005, p. 133-138.

Research output: Contribution to journalArticle

Ernst, Armin ; Simoff, Michael J. ; Mathur, Praveen N. ; Yung, Rex C. ; Beamis, John F. / D-light autofluorescence in the detection of premalignant airway changes : A multicenter trial. In: Journal of Bronchology. 2005 ; Vol. 12, No. 3. pp. 133-138.
@article{7a9110ba25ea4e85834463eb458bf584,
title = "D-light autofluorescence in the detection of premalignant airway changes: A multicenter trial",
abstract = "Carcinoma in situ and preinvasive lesions are difficult to detect by white light (WL) bronchoscopy. Autofluorescence (AF) bronchoscopy is an emerging technology that may increase the ability for early detection and curative treatment. We report on the effectiveness of an autofluorescence system to detect class III lesions in a large population. A multicenter prospective, nonrandomized, self-controlled study was performed in 5 university-affiliated tertiary care centers. Patients at high risk for pulmonary malignancies were eligible to undergo WL and AF bronchoscopy. Patients underwent biopsy of all suspicious class III lesions, as well as 2 biopsies from normal areas. Three hundred patients were included in the study; of those, 293 patients were included into the efficacy calculations with 832 biopsies. AF was superior to WL in sensitivity (61.2{\%} vs. 10.6{\%}) for detecting class III lesions (visual changes suggesting dysplasia, carcinoma in situ, or microinvasive cancer). The combined sensitivity was 65.9{\%}. Specificity values were 75.3{\%} and 72.7{\%}, respectively, for AF and WL. On a per-patient basis harboring at least 1 premalignant area, the sensitivity for WL was 21.1{\%} as compared with 84.2{\%} for AF. Three deaths occurred within the study period but were unrelated to the device. In conclusion, the AF system is superior to conventional WL bronchoscopy in detecting premalignant lesions in a population at risk.",
keywords = "Autofluorescence, Bronchoscopy, Lung cancer, Screening",
author = "Armin Ernst and Simoff, {Michael J.} and Mathur, {Praveen N.} and Yung, {Rex C.} and Beamis, {John F.}",
year = "2005",
month = "7",
doi = "10.1097/01.laboratory.0000172752.26207.e5",
language = "English (US)",
volume = "12",
pages = "133--138",
journal = "Journal of Bronchology and Interventional Pulmonology",
issn = "1944-6586",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - D-light autofluorescence in the detection of premalignant airway changes

T2 - A multicenter trial

AU - Ernst, Armin

AU - Simoff, Michael J.

AU - Mathur, Praveen N.

AU - Yung, Rex C.

AU - Beamis, John F.

PY - 2005/7

Y1 - 2005/7

N2 - Carcinoma in situ and preinvasive lesions are difficult to detect by white light (WL) bronchoscopy. Autofluorescence (AF) bronchoscopy is an emerging technology that may increase the ability for early detection and curative treatment. We report on the effectiveness of an autofluorescence system to detect class III lesions in a large population. A multicenter prospective, nonrandomized, self-controlled study was performed in 5 university-affiliated tertiary care centers. Patients at high risk for pulmonary malignancies were eligible to undergo WL and AF bronchoscopy. Patients underwent biopsy of all suspicious class III lesions, as well as 2 biopsies from normal areas. Three hundred patients were included in the study; of those, 293 patients were included into the efficacy calculations with 832 biopsies. AF was superior to WL in sensitivity (61.2% vs. 10.6%) for detecting class III lesions (visual changes suggesting dysplasia, carcinoma in situ, or microinvasive cancer). The combined sensitivity was 65.9%. Specificity values were 75.3% and 72.7%, respectively, for AF and WL. On a per-patient basis harboring at least 1 premalignant area, the sensitivity for WL was 21.1% as compared with 84.2% for AF. Three deaths occurred within the study period but were unrelated to the device. In conclusion, the AF system is superior to conventional WL bronchoscopy in detecting premalignant lesions in a population at risk.

AB - Carcinoma in situ and preinvasive lesions are difficult to detect by white light (WL) bronchoscopy. Autofluorescence (AF) bronchoscopy is an emerging technology that may increase the ability for early detection and curative treatment. We report on the effectiveness of an autofluorescence system to detect class III lesions in a large population. A multicenter prospective, nonrandomized, self-controlled study was performed in 5 university-affiliated tertiary care centers. Patients at high risk for pulmonary malignancies were eligible to undergo WL and AF bronchoscopy. Patients underwent biopsy of all suspicious class III lesions, as well as 2 biopsies from normal areas. Three hundred patients were included in the study; of those, 293 patients were included into the efficacy calculations with 832 biopsies. AF was superior to WL in sensitivity (61.2% vs. 10.6%) for detecting class III lesions (visual changes suggesting dysplasia, carcinoma in situ, or microinvasive cancer). The combined sensitivity was 65.9%. Specificity values were 75.3% and 72.7%, respectively, for AF and WL. On a per-patient basis harboring at least 1 premalignant area, the sensitivity for WL was 21.1% as compared with 84.2% for AF. Three deaths occurred within the study period but were unrelated to the device. In conclusion, the AF system is superior to conventional WL bronchoscopy in detecting premalignant lesions in a population at risk.

KW - Autofluorescence

KW - Bronchoscopy

KW - Lung cancer

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=23044442788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23044442788&partnerID=8YFLogxK

U2 - 10.1097/01.laboratory.0000172752.26207.e5

DO - 10.1097/01.laboratory.0000172752.26207.e5

M3 - Article

VL - 12

SP - 133

EP - 138

JO - Journal of Bronchology and Interventional Pulmonology

JF - Journal of Bronchology and Interventional Pulmonology

SN - 1944-6586

IS - 3

ER -